Literature DB >> 12069956

In vitro increase in chloroquine accumulation induced by dihydroethano- and ethenoanthracene derivatives in Plasmodium falciparum-parasitized erythrocytes.

Bruno Pradines1, Sandrine Alibert, Carole Houdoin, Christiane Santelli-Rouvier, Joel Mosnier, Thierry Fusai, Christophe Rogier, Jacques Barbe, Daniel Parzy.   

Abstract

The effects of a series of dihydroethano- and ethenoanthracene derivatives on chloroquine (CQ) accumulation in CQ-susceptible strain 3D7 and CQ-resistant clone W2 were assessed. The levels of CQ accumulation increased little or none in CQ-susceptible strain 3D7 and generally increased markedly in CQ-resistant strain W2. At 10 microM, 28 compounds yielded cellular accumulation ratios (CARs) greater than that observed with CQ alone in W2. At 10 microM, in strain W2, 21 of 31 compounds had CQ CARs two or more times higher than that of CQ alone, 15 of 31 compounds had CQ CARs three or more times higher than that of CQ alone, 13 of 31 compounds had CQ CARs four or more times higher than that of CQ alone, and 9 of 31 compounds had CQ CARs five or more times higher than that of CQ alone. At 1 microM, 17 of 31 compounds had CQ CARs two or more times higher than that of CQ alone, 12 of 31 compounds had CQ CARs three or more times higher than that of CQ alone, 6 of 31 compounds had CQ CARs four or more times higher than that of CQ alone, and 3 of 31 compounds had CQ CARs five or more times higher than that of CQ alone. At 1 microM, 17 of 31 compounds were more potent inducers of CQ accumulation than verapamil and 12 of 31 compounds were more potent inducers of CQ accumulation than promethazine. The nature of the basic group seems to be associated with increases in the levels of CQ accumulation. At 1 and 10 microM, 10 of 14 and 13 of 14 compounds with amino group (amines and diamines), respectively, had CARs >or=3, while at 1 and 10 microM, only 1 of the 13 derivatives with amido groups had CARs >or=3. Among 12 of the 31 compounds which were more active inducers of CQ accumulation than promethazine at 1 microM, 10 had amino groups and 1 had an amido group.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069956      PMCID: PMC127304          DOI: 10.1128/AAC.46.7.2061-2068.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  57 in total

1.  Reversal of chloroquine resistance of 'wild' isolates of Plasmodium falciparum by desipramine.

Authors:  G Carosi; S Caligaris; G Fadat; F Castelli; A Matteelli; D Kouka-Bemba; G Roscigno
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Nov-Dec       Impact factor: 2.184

2.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites.

Authors:  A F Slater; A Cerami
Journal:  Nature       Date:  1992-01-09       Impact factor: 49.962

3.  Alleles of the Plasmodium falciparum Pfmdr1 gene appear not to be associated with chloroquine resistance in India.

Authors:  P R Bhattacharya; S Biswas; L Kabilan
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Jul-Aug       Impact factor: 2.184

4.  In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine.

Authors:  A M Oduola; A Sowunmi; W K Milhous; T G Brewer; D E Kyle; L Gerena; R N Rossan; L A Salako; B G Schuster
Journal:  Am J Trop Med Hyg       Date:  1998-05       Impact factor: 2.345

5.  Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine.

Authors:  A J Bitonti; A Sjoerdsma; P P McCann; D E Kyle; A M Oduola; R N Rossan; W K Milhous; D E Davidson
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

6.  Reversal of chloroquine resistance in Plasmodium falciparum using combinations of chemosensitizers.

Authors:  D A van Schalkwyk; J C Walden; P J Smith
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

7.  Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum.

Authors:  S R Karcz; D Galatis; A F Cowman
Journal:  Mol Biochem Parasitol       Date:  1993-04       Impact factor: 1.759

8.  Reversal of chloroquine resistance in falciparum malaria.

Authors:  J C Ryall
Journal:  Parasitol Today       Date:  1987-08

9.  Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys.

Authors:  D E Kyle; W K Milhous; R N Rossan
Journal:  Am J Trop Med Hyg       Date:  1993-01       Impact factor: 2.345

10.  Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand.

Authors:  C M Wilson; S K Volkman; S Thaithong; R K Martin; D E Kyle; W K Milhous; D F Wirth
Journal:  Mol Biochem Parasitol       Date:  1993-01       Impact factor: 1.759

View more
  2 in total

1.  Polymorphism in plasmodium falciparum drug transporter proteins and reversal of in vitro chloroquine resistance by a 9,10-dihydroethanoanthracene derivative.

Authors:  Julie Millet; Sandrine Alibert; Marylin Torrentino-Madamet; Christophe Rogier; Christiane Santelli-Rouvier; Patricia Bigot; Joel Mosnier; Eric Baret; Jacques Barbe; Daniel Parzy; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Dihydroethanoanthracene derivatives as in vitro malarial chloroquine resistance reversal agents.

Authors:  Julie Millet; Marylin Torrentino-Madamet; Sandrine Alibert; Christophe Rogier; Christiane Santelli-Rouvier; Joel Mosnier; Eric Baret; Jacques Barbe; Daniel Parzy; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.